Avidity Partners Management LP Pliant Therapeutics, Inc. Transaction History

Avidity Partners Management LP

  • $1.63 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$18.12 - $30.56 $31.7 Million - $53.4 Million
-1,748,400 Reduced 65.61%
916,600 $16.6 Million
Q1 2023

May 15, 2023
BUY
$18.73 - $36.26 $7.95 Million - $15.4 Million
424,600 Added 18.95%
2,665,000 $70.9 Million
Q4 2022

Feb 14, 2023
BUY
$17.0 - $25.43 $4.41 Million - $6.59 Million
259,300 Added 13.09%
2,240,400 $43.3 Million
Q3 2022

Nov 14, 2022
BUY
$7.67 - $24.23 $15.2 Million - $48 Million
1,981,100 New
1,981,100 $41.4 Million

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email